The hub proteins, such as CCT4, EZR, and GAPDH, are known to be involved in critical pathways like neutrophil degranulation and sirtuin signaling, which are linked to the altered metabolic profiles and increased cancer stemness observed in neoadjuvant-treated PDAC. This evidence concerns the gene EZR and cancer.